http://www.unboundmedicine.com/medline/ebm/research/altretamineUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19654952/full_citation/Hexamethylmelamine_as_consolidation_treatment_for_patients_with_advanced_epithelial_ovarian_cancer_in_complete_response_after_first_line_chemotherapy_Kwon YS, Nam JH, Kim DY, et al. 
Hexamethylmelamine as consolidation treatment for patients with advanced epithelial ovarian cancer in complete response after first-line chemotherapy. [Journal Article]
J Korean Med Sci 2009 Aug; 24(4):679-83.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18811611/full_citation/Relationship_between_frailty_and_cognitive_decline_in_older_Mexican_Americans_Samper-Ternent R, Al Snih S, Raji MA, et al. 
Relationship between frailty and cognitive decline in older Mexican Americans. [Journal Article, Research Support, N.I.H., Extramural]
J Am Geriatr Soc 2008 Oct; 56(10):1845-52.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18665286/full_citation/Atom_efficient_cyclotrimerization_of_dimethylcyanamide_catalyzed_by_aluminium_amide:_a_combined_experimental_and_theoretical_investigation_Dornan P, Rowley CN, Priem J, et al. 
Atom efficient cyclotrimerization of dimethylcyanamide catalyzed by aluminium amide: a combined experimental and theoretical investigation. [Journal Article]
Chem Commun (Camb) 2008 Aug 21; (31):3645-7.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18591551/full_citation/Lessons_from_a_time_capsule:_evolution_not_revolution_in_therapy_for_advanced_non_small_cell_lung_cancer_Green MR 
Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer. [Comment, Journal Article]
J Clin Oncol 2008 Jul 1; 26(19):3112-3.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/18305940/full_citation/Synergy_of_irofulven_in_combination_with_other_DNA_damaging_agents:_synergistic_interaction_with_altretamine_alkylating_and_platinum_derived_agents_in_the_MV522_lung_tumor_model_Kelner MJ, McMorris TC, Rojas RJ, et al. 
Synergy of irofulven in combination with other DNA damaging agents: synergistic interaction with altretamine, alkylating, and platinum-derived agents in the MV522 lung tumor model. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2008 Feb 28.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/16549840/full_citation/Pretreatment_CA_125_and_risk_of_relapse_in_advanced_ovarian_cancer_Markman M, Liu PY, Rothenberg ML, et al. 
Pretreatment CA-125 and risk of relapse in advanced ovarian cancer. [Journal Article]
J Clin Oncol 2006 Mar 20; 24(9):1454-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/16249349/full_citation/Topotecan:_weighing_in_when_there_are_many_options_Penson RT, Seiden MV 
Topotecan: weighing in when there are many options. [Comment, Journal Article]
Oncologist 2005 Oct; 10(9):698-700.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/16151309/full_citation/Better_treatments_improve_survival_of_CHD_patients_Ninivaggi L 
Better treatments improve survival of CHD patients. [Journal Article, Review]
Nurse Pract 2005 Sep; 30(9):57-63.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/15569973/full_citation/Recurrent_ovarian_cancer:_how_important_is_it_to_treat_to_disease_progressionHerzog TJ 
Recurrent ovarian cancer: how important is it to treat to disease progression? [Journal Article, Review]
Clin Cancer Res 2004 Nov 15; 10(22):7439-49.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/15086720/full_citation/Long_term_follow_up_of_a_phase_II_trial_of_oral_altretamine_for_consolidation_of_clinical_complete_remission_in_women_with_stage_III_epithelial_ovarian_cancer_in_the_Southwest_Oncology_Group_Alberts DS, Jiang C, Liu PY, et al. 
Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology Group. [Journal Article, Multicenter Study]
Int J Gynecol Cancer 2004 Mar-Apr; 14(2):224-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles